GEFITINIB

Generic: GEFITINIB

Teva PharmaceuticalsManufacturer
ORALRoute
GEFITINIBActive Substance
2023-04-26Original Approval

GEFITINIB is FDA application ANDA208913, sponsored by ACTAVIS LABS FL INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
MALIGNANT NEOPLASM PROGRESSION
609 reports
2
DRUG RESISTANCE
490 reports
3
ACQUIRED GENE MUTATION
220 reports
4
DIARRHOEA
163 reports
5
DISEASE PROGRESSION
148 reports
6
RASH
144 reports
7
METASTASES TO CENTRAL NERVOUS SYSTEM
111 reports
8
EGFR GENE MUTATION
110 reports
9
DEATH
108 reports
10
OFF LABEL USE
89 reports